Legend Biotech (LEGN) Return on Invested Capital (2023 - 2025)

Legend Biotech has reported Return on Invested Capital for 3 years, with the latest figure at 0.01% in Q4 2025.

• For the quarter ending Q4 2025, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the trailing twelve-month figure through Dec 2025 stood at 0.01% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital for Q4 2025 stood at 0.01%, up from 0.0% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.69% in Q3 2024, with the low at 0.0% in Q4 2024.
• Historically, Return on Invested Capital has averaged 0.22% across 3 years, with a median of 0.01% in 2023.
• Annual changes were most pronounced in 2024 — Return on Invested Capital jumped 69 bps — and 2025, when it slumped 69 bps.
• Legend Biotech's Return on Invested Capital stood at 0.56% in 2023, then slumped by 100 bps to 0.0% in 2024, then surged by 101 bps to 0.01% in 2025.
• The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025), per Business Quant data.